Literature DB >> 30138915

Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients.

Sandra Santasusagna1, Isabel Moreno2, Alfons Navarro1, Francisco Martinez Rodenas2, Raquel Hernández2, Joan J Castellano1, Carmen Muñoz1, Mariano Monzo1.   

Abstract

OBJECTIVE: To evaluate the prognostic potential of expression levels of miR-200 family members (miR-200a, miR-200b, miR-200c, miR-429, miR-141) in plasma and exosomes from the tumor-draining vein (mesenteric vein [MV]) and peripheral vein (PV) of colon cancer (CC) patients.
METHODS: We analyzed the expression of miR-200 family members in matched samples of MV and PV plasma from 50 resected patients with CC and correlated our findings with overall survival (OS). We also examined the content of these microRNAs in MV and PV exosomes.
RESULTS: Expression levels were higher in MV than in PV (miR-200a, p < 0.001; miR-200b, p < 0.001; miR-429, p = 0.01; miR-200c, p = 0.05; miR-141, p = 0.05). Low levels of both miR-200c and miR-141 in MV plasma were associated with longer OS (p = 0.02). This association was maintained for the MV exosome cargo of miR-200c and miR-141 (p = 0.02).
CONCLUSION: Our findings provide the first indication that expression levels of miR-200c and miR-141 in MV plasma can identify CC patients with poor prognosis. In addition, our results lend further support to the premise that tumor-draining veins constitute a better source of biomarkers than do PVs.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Colon cancer; Exosomes; Tumor-draining vein; miR-141; miR-200c

Mesh:

Substances:

Year:  2018        PMID: 30138915     DOI: 10.1159/000490726

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  17 in total

1.  Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer.

Authors:  Ganghua Yang; Zhengyang Lu; Fandi Meng; Yong Wan; Lei Zhang; Qinhong Xu; Zheng Wang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

2.  MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma.

Authors:  Xiao Cui; Dachen Zhou; Qiang Du; Peiqi Wan; Kun Dong; Hui Hou; David A Geller
Journal:  Transl Oncol       Date:  2020-06-17       Impact factor: 4.243

3.  Clinical significance of exosomes as potential biomarkers in cancer.

Authors:  Chi-Hin Wong; Yang-Chao Chen
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

Review 4.  Circulating Extracellular Vesicle MicroRNA as Diagnostic Biomarkers in Early Colorectal Cancer-A Review.

Authors:  Brendan J Desmond; Elizabeth R Dennett; Kirsty M Danielson
Journal:  Cancers (Basel)       Date:  2019-12-23       Impact factor: 6.639

Review 5.  Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer.

Authors:  Valentin Vautrot; Gaëtan Chanteloup; Mohammed Elmallah; Marine Cordonnier; François Aubin; Carmen Garrido; Jessica Gobbo
Journal:  J Oncol       Date:  2019-10-13       Impact factor: 4.375

Review 6.  Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles.

Authors:  Ines Stevic; Gustav Buescher; Franz Lennard Ricklefs
Journal:  Cells       Date:  2020-01-06       Impact factor: 6.600

7.  Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer.

Authors:  Qiliang Peng; Ming Cheng; Ting Li; Xiangying Chen; Yi Shen; Yaqun Zhu; Bo Xu
Journal:  Cancer Cell Int       Date:  2020-02-18       Impact factor: 5.722

Review 8.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 9.  Colorectal liver metastasis: molecular mechanism and interventional therapy.

Authors:  Hui Zhou; Zhongtao Liu; Yongxiang Wang; Xiaoyong Wen; Eric H Amador; Liqin Yuan; Xin Ran; Li Xiong; Yuping Ran; Wei Chen; Yu Wen
Journal:  Signal Transduct Target Ther       Date:  2022-03-04

10.  Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.

Authors:  Jingchao Xu; Yang Xiao; Bing Liu; Shimeng Pan; Qianqian Liu; Yujia Shan; Shuangda Li; Yu Qi; Yiran Huang; Li Jia
Journal:  J Exp Clin Cancer Res       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.